These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18339878)

  • 1. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
    Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S
    Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
    Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
    Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
    Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
    PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.
    Liang Y; Yin D; Hou L; Zheng T; Wang J; Meng X; Lu Z; Song X; Pan S; Jiang H; Liu L
    PLoS One; 2011; 6(8):e23908. PubMed ID: 21901145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
    He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
    Yang CH; Yue J; Sims M; Pfeffer LM
    PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.
    Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H
    Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells.
    Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F
    Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
    Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G
    J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression.
    Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P
    J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
    Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
    Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2.
    Zhang P; Bai H; Liu G; Wang H; Chen F; Zhang B; Zeng P; Wu C; Peng C; Huang C; Song Y; Song E
    Toxicol Lett; 2015 May; 234(3):151-61. PubMed ID: 25725129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
    Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
    Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
    Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
    Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
    Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
    Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer.
    Chen W; Zou P; Zhao Z; Chen X; Fan X; Vinothkumar R; Cui R; Wu F; Zhang Q; Liang G; Ji J
    Redox Biol; 2016 Dec; 10():78-89. PubMed ID: 27697670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
    Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer.
    Chen X; Dai X; Zou P; Chen W; Rajamanickam V; Feng C; Zhuge W; Qiu C; Ye Q; Zhang X; Liang G
    Br J Pharmacol; 2017 May; 174(10):1131-1146. PubMed ID: 28255993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.
    Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P
    Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.
    Chen C; Liu Y; Chen Y; Xu J
    Cancer Biol Ther; 2011 Nov; 12(9):797-807. PubMed ID: 21900746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.